PURINE METABOLISM IN LEUKOCYTES AND ERYTHROCYTES IN GRAVES' OR HASHIMOTO'S DISEASE
暂无分享,去创建一个
[1] M. Tagawa,et al. Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts. , 2000, Cancer letters.
[2] R. Lechler,et al. Detection of CD40 on human thyroid follicular cells: analysis of expression and function. , 1998, The Journal of clinical endocrinology and metabolism.
[3] M. Béné,et al. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. , 1997, Clinical immunology and immunopathology.
[4] D. Wyczechowska,et al. Comparison of the Inhlbitory Effects of 2-Chloro-2′-deoxyadenosine and 9-β-D-Arabinosyl-2-fluoro-adenine on Metabolism of Deoxyadenosine in Human Lymphocytes and Erythrocytes , 1997 .
[5] K. Törnquist,et al. Adenosine inhibits DNA synthesis stimulated with TSH, insulin, and phorbol 12‐Myristate 13‐Acetate in rat thyroid FRTL‐5 cells , 1997, Journal of cellular physiology.
[6] C. Di Pietro,et al. Purine nucleotide metabolism: specific aspects in chronic lymphocytic leukemia lymphocytes. , 1997, Biochimica et biophysica acta.
[7] R. Noelle,et al. Suppression of murine thyroiditis via blockade of the CD40–CD40L interaction , 1997, Immunology.
[8] N. Mahy,et al. Differential effects of 2′‐deoxyguanosine on peripheral blood mononuclear cell proliferation in healthy donors and Hashimoto's thyroiditis patients , 1996, Cell proliferation.
[9] R. Noelle,et al. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. , 1996, Thyroid : official journal of the American Thyroid Association.
[10] J Bajorath,et al. Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.
[11] K. Tybor,et al. The influence of 2-chloro-2'-deoxyadenosine on metabolism of deoxyadenosine in human primary CNS lymphoma. , 1995, Biochemical pharmacology.
[12] H. Simmonds,et al. Effects of novel anti-viral adenosine analogues on the activity of S-adenosylhomocysteine hydrolase from human liver. , 1994, Biochemical pharmacology.
[13] J. Blay,et al. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. , 1994, Cancer research.
[14] K. Fabianowska-Majewska,et al. Adenosine deaminase: physical and chemical properties of partially purified mitochondrial and cytosol enzyme from rat liver. , 1992, Acta biochimica Polonica.
[15] S. Polmar,et al. Adenosine induced immunosuppression: the role of the adenosine receptor--adenylate cyclase interaction in the alteration of T-lymphocyte surface phenotype and immunoregulatory function. , 1986, International journal of immunopharmacology.
[16] H. Simmonds,et al. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency. , 1985, Biochemical pharmacology.
[17] E. Giblett. ADA and PNP Deficiencies: How It All Began , 1985, Annals of the New York Academy of Sciences.
[18] L. Thompson,et al. Lymphocyte ecto-5'-nucleotidase activity in infancy: increasing activity in peripheral blood B cells precedes their ability to synthesize IgG in vitro. , 1984, Journal of immunology.
[19] M. Weyden,et al. PLASMA THYMIDINE KINASE IN MEGALOBLASTIC ANAEMIA , 1980, British journal of haematology.
[20] J. Sedmak,et al. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. , 1977, Analytical biochemistry.
[21] J H Chloropos,et al. How it all began. , 1967, JAMA.